The Cytochrome P450 2B6 (CYP2B6) Is the Main Catalyst of Efavirenz Primary and Secondary Metabolism: Implication for HIV/AIDS Therapy and Utility of Efavirenz as a Substrate Marker of CYP2B6 Catalytic Activity

Bryan A. Ward(Indiana University School of Medicine), J. Christopher Gorski(Indiana University Bloomington), David R. Jones, Stephen D. Hall(Indiana University Bloomington), David A. Flockhart, Zeruesenay Desta
Journal of Pharmacology and Experimental Therapeutics
June 18, 2003
Cited by 594

Abstract


Related Papers

No related papers found

Powered by citation graph analysis